✦ LIBER ✦

Development of a drug–disease simulation model for rituximab in follicular non-Hodgkin's lymphoma

✍ Scribed by David Ternant; Emilie Hénin; Guillaume Cartron; Michel Tod; Gilles Paintaud; Pascal Girard

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of autologous cytotoxic CD4+

✍ Jian-Qing Mi; Olivier Manches; Jin Wang; Pascal Perron; Sébastien Weisbuch; Patr 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

PCN46 A COST UTILITY ANALYSIS OF MAINTEN

✍ U Geary; G Lewis; R Aultman; M Aristides 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

A quality-adjusted survival analysis (Q-

✍ Marcus, R; Aultman, R; Jost, F 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 264 KB

The Cost-Effectiveness of Bendamustine-R

✍ Bertwistle, D.; Munakata, J.; Wehler, E.; Leyva, V.; Valencia, A.; Hernandez, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

The Cost-Effectiveness of Bendamustine-R

✍ Bertwistle, D.; Munakata, J.; Wehler, E; Leyva, V.; Ariza, J.G.; Zambrano, C.; G 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

A randomized trial of etoposide and G-CS

✍ Copelan, E; Pohlman, B; Rybicki, L; Kalaycio, M; Sobecks, R; Andresen, S; Dean, 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB